Aligos Therapeutics, Inc. earnings per share and revenue

ALGS earnings per share for the last quarter are -0.22 USD whereas the estimation was -0.28 USD which accounts for 21.43% surprise. Company revenue for the same period amounts to 2.01 M USD despite the estimated figure of 1.60 M USD. Estimated earnings per share for the next quarter are -0.19 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of ALGS earnings per share and revenue dynamics.